financetom
Business
financetom
/
Business
/
Bath & Body Works Fiscal Q4 Adjusted Earnings Increase, Revenue Declines
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bath & Body Works Fiscal Q4 Adjusted Earnings Increase, Revenue Declines
Feb 27, 2025 4:18 AM

06:56 AM EST, 02/27/2025 (MT Newswires) -- Bath & Body Works ( BBWI ) reported fiscal Q4 adjusted earnings Thursday of $2.09 per diluted share, up from $2.06 a year earlier.

Analysts polled by FactSet expected $2.04.

Revenue for the fiscal quarter ended Feb. 1 was $2.79 billion, down from $2.91 billion a year earlier.

Analysts surveyed by FactSet expected $2.78 billion.

For fiscal Q1, the specialty fragrance and cosmetics retailer expects EPS of $0.36 to $0.43. Analysts polled by FactSet expect EPS of $0.44. Net sales growth for the fiscal quarter is projected to be 1% to 3%. Analysts surveyed by FactSet expect $1.42 billion.

For fiscal 2025, the company expects EPS of $3.25 to $3.60. Analysts polled by FactSet expect EPS of $3.40. Meanwhile, net sales growth for the fiscal year is projected to be between 1% and 3%. Analysts polled by FactSet expect revenue of $7.30 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Healwell AI Subsidiary Partners With Sunnybrook Hospital to Show AI Platform Role in Cancer Staging
Healwell AI Subsidiary Partners With Sunnybrook Hospital to Show AI Platform Role in Cancer Staging
May 21, 2024
07:16 AM EDT, 05/21/2024 (MT Newswires) -- Healwell AI (AIDX.TO), which gained 10% last Friday, said its subsidiary Pentavere Research Group, partnered with Sunnybrook Health Sciences Centre in Toronto and Dr. Tony Eskander, a head and neck surgical oncologist there, to demonstrate how Pentavere's Darwen AI platform can help improve cancer staging to support treatment decisions and improve patient outcomes....
AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion
AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion
May 21, 2024
Tuesday, AstraZeneca Plc ( AZN )  announced its ambitious plan to increase its total revenue to $80 billion by 2030, a significant rise from $45.8 billion in 2023.  Substantial expansion in its oncology, biopharmaceuticals, and rare disease portfolios and introducing 20 new medicines by the decade’s end will fuel the growth.  To sustain growth beyond 2030, the company will invest in transformative technologies...
Dye & Durham Commences Substantial Issuer Bid
Dye & Durham Commences Substantial Issuer Bid
May 21, 2024
07:17 AM EDT, 05/21/2024 (MT Newswires) -- Dye & Durham ( DYNDF ) over the holiday weekend said it has initiated a substantial issuer bid to buy back for cancellation up to $185 million of its issued and outstanding 3.75% convertible senior unsecured debentures due March 1, 2026. The offer will expire on June 21, unless extended, varied, or withdrawn....
Ethereum, Bitcoin Continue Rally Amid Optimism on Spot Ether ETF Applications
Ethereum, Bitcoin Continue Rally Amid Optimism on Spot Ether ETF Applications
May 21, 2024
07:13 AM EDT, 05/21/2024 (MT Newswires) -- Major cryptocurrencies bitcoin (BTC) and ethereum (ETH) continued to rally early Tuesday, buoyed by market optimism ahead of the US Securities and Exchange Commission's decision on certain spot ether ETF applications this week. Ethereum was up more than 19% at $3,710, while bitcoin was over 5% higher at $70,991. According to a Reuters...
Copyright 2023-2026 - www.financetom.com All Rights Reserved